According to Bloomberg, about three-quarters of S&P 500 companies have already reported third-quarter financial results and profits have not been great – down 3.1% on a share-weighted basis due to plunging earnings from oil & gas and commodity-related companies. These figures reveal the biggest quarterly drop in earnings since Q3 of 2009, and the second straight period of profit declines. That being said, the six stocks on our list today have actually increased earnings and revenues from Q3/2014.
Sabre Corp. (NASDAQ: SABR) – $29.17
Software
Sabre Corporation (Sabre) is a technology solutions provider to the global travel and tourism industry. The Company operates in two segments: Travel Network, which is a global business-to-business travel marketplace for travel suppliers and travel buyers, and Airline and Hospitality Solutions, which provides a suite of software solutions, primarily for airlines and hotel properties.
- Market Cap: 8,290,375,129
- Revenues (LTM): $785,002,000
- Growth in Income (over Q3/2014): 335.3%
- Growth in Revenues (over Q3/2014): 16.7%
Interactive Brokers Group Inc. (NASDAQ: IBKR) – $41.97
Financial & Commodity Market Operators
Interactive Brokers Group, Inc. (IBG, Inc.) is a holding company with an automated global electronic broker and market maker specializing in routing orders, and executing and processing trades in securities, futures, foreign exchange instruments, bonds and mutual funds on more than 100 electronic exchanges and trading venues around the world. It operates in two segments: electronic brokerage and market making.
- Market Cap: $17,077,583,073
- Revenues (LTM): $375,000,000
- Growth in Income (over Q3/2014): 589.4%
- Growth in Revenues (over Q3/2014): 92.2%
Adobe Systems Inc. (NASDAQ: ADBE) – $90.55
Software
Adobe Systems Incorporated (Adobe) is a software company that offers products and services for professionals, marketers, application developers, enterprises and consumers for creating, managing, delivering, optimizing and engaging with content. Adobe markets and licenses its products and services through app stores and its Website www.adobe.com. The Company’s operates in three segments: Digital Marketing, Digital Media, and Print and Publishing.
- Market Cap: $45,395,728,752
- Revenues (LTM): $1,217,768,000
- Growth in Income (over Q3/2014): 290.4%
- Growth in Revenues (over Q3/2014): 21.1%
Looking for more hidden gems? Get your free Ubika Energy 20 Monthly report.
The Ubika Energy 20 (UE20) index jumped 5.3% in October, after surging 10% the month before. The TSX Capped Energy Index, however, gained 7.5% during this time while the WTI crude oil price advanced 3.3% to US$46.59/barrel. Mart Resources, Inc. (TSX: MMT) was the top-performing component company this month, powering 55% higher after agreeing to be acquired by Delta Oil Nigeria B.V. for C$0.35 a share.
Get your copy of the Ubika Energy 20 report here >>
Vornado Realty Trust (NYSE: VNO) – $99.78
Commercial REITs
Vornado Realty Trust (Vornado) is a fully-integrated real estate investment trust (REIT). The Company conducts its business through, and substantially all of its interests in properties are held by, Vornado Realty L.P. (the Operating Partnership). The Company is the sole general partner of, and owned approximately 94.1% of the common limited partnership interest in the Operating Partnership.
- Market Cap: $18,835,233,512
- Revenues (LTM): $627,596,000
- Growth in Income (over Q3/2014): 347.7%
- Growth in Revenues (over Q3/2014): 8.4%
Antero Resources Corp. (NYSE: AR) – $25.03
Oil & Gas Exploration and Production
Antero Resources Corporation is engaged in the exploitation, development, and acquisition of natural gas, natural gas liquids (NGLs) and oil properties in the Appalachian Basin in West Virginia, Ohio, and Pennsylvania. The Company targets large, repeatable resource plays where horizontal drilling and advanced fracture stimulation technologies provide the means to develop and produce natural gas, NGLs and oil from unconventional formations.
- Market Cap: $7,098,002,067
- Revenues (LTM): $1,443,335,000
- Growth in Income (over Q3/2014): 161.8%
- Growth in Revenues (over Q3/2014): 89.3%
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) – $564.16
Biotechnology & Medical Research
Regeneron Pharmaceuticals, Inc. is an integrated biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates under development in other areas, including hypercholesterolemia, oncology, rheumatoid arthritis (RA), asthma and atopic dermatitis.
- Market Cap: $58,480,258,728
- Revenues (LTM): $1,137,422,000
- Growth in Income (over Q3/2014): 152.4%
- Growth in Revenues (over Q3/2014): 56.7%
